Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;16(5):39.
doi: 10.1007/s11892-016-0732-8.

Diagnosis and Management of IUGR in Pregnancy Complicated by Type 1 Diabetes Mellitus

Paweł Gutaj  1 , Ewa Wender-Ozegowska  2
Affiliations
Review

Diagnosis and Management of IUGR in Pregnancy Complicated by Type 1 Diabetes Mellitus

Paweł Gutaj et al. Curr Diab Rep. 2016 May.

Abstract

This review discusses available literature on the diagnosis and management of intrauterine growth restriction (IUGR) in women with type 1 diabetes. IUGR is diagnosed when ultrasound-estimated fetal weight is below the 10th percentile for gestational age. IUGR diagnosis implies a pathologic process behind low fetal weight. IUGR in pregnancy complicated by type 1 diabetes is usually caused by placental dysfunction related to maternal vasculopathy. Prevention of IUGR should ideally start before pregnancy. Strict glycemic control and intensive treatment of nephropathy and hypertension are essential. Low-dose aspirin initiated before 16 gestational weeks can also reduce IUGR risk in women with vasculopathy. Umbilical and uterine artery Doppler studies can guide diagnosis and surveillance of fetuses with IUGR. Decisions regarding the timing of delivery should be based on assessment of umbilical artery Doppler. The risk of prematurity and impaired fetal lung maturation should always be considered, especially in fetuses younger than 32 weeks.

Keywords: IUGR; Intrauterine growth restriction; SGA; Small for gestational age; Type 1 diabetes; Vasculopathy.

PubMed Disclaimer

References

    1. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311(6998):171–4. doi: 10.1136/bmj.311.6998.171. - DOI - PMC - PubMed
    1. Morgan AR, Thompson JM, Murphy R, Black PN, Lam WJ, Ferguson LR, et al. Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. BMC Med Genet. 2010;11:125. doi: 10.1186/1471-2350-11-125. - DOI - PMC - PubMed
    1. ACOG ACOG practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–33. doi: 10.1097/01.AOG.0000429658.85846.f9. - DOI - PubMed
    1. RCOG . Green-top guideline no. 31: the investigation and management of the small-for-gestational-age fetus. 2013.
    1. Lausman A, Kingdom J, Gagnon R, Basso M, Bos H, Crane J, et al. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013;35(8):741–57. doi: 10.1016/S1701-2163(15)30865-3. - DOI - PubMed

LinkOut - more resources